| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZSCAN12 HIVEP2 ZSCAN5A SRF POU3F4 HNF4A FOXJ3 CLOCK ELL3 MEIS2 HSF5 IKZF5 ZSCAN5B TFCP2L1 ZFHX4 GLI3 NFYC NFAT5 FOXK1 ZFP62 TBX5 RAD23B | 2.32e-05 | 1271 | 130 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZSCAN12 HIVEP2 ZSCAN5A SRF POU3F4 HNF4A FOXJ3 CLOCK MEIS2 HSF5 IKZF5 ZSCAN5B TFCP2L1 ZFHX4 GLI3 NFYC NFAT5 FOXK1 ZFP62 TBX5 RAD23B | 5.25e-05 | 1244 | 130 | 21 | GO:0000978 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZSCAN12 HIVEP2 ZSCAN5A SRF POU3F4 HNF4A FOXJ3 CLOCK CREBBP MEIS2 HSF5 IKZF5 ZSCAN5B TFCP2L1 ZFHX4 GLI3 NFYC NFAT5 FOXK1 ZFP62 TBX5 RAD23B | 1.78e-04 | 1459 | 130 | 22 | GO:0000977 |
| GeneOntologyMolecularFunction | chromatin binding | ASXL1 ERCC6 EP400 SRF SIN3A UPF1 HNF4A CLOCK CREBBP IKZF5 NCOA5 PRDM11 GLI3 NFAT5 | 3.31e-04 | 739 | 130 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | ASXL1 CRTC3 SRF HIPK2 TACC2 SIN3A HNF4A CLOCK CREBBP MEIS2 ARID2 NFAT5 TBX5 RAD23B | 4.00e-04 | 753 | 130 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA helicase activity | 7.14e-04 | 62 | 130 | 4 | GO:0003678 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ASXL1 CRTC3 HIVEP2 ERCC6 SRF AKNA HIPK2 HNF4A FOXJ3 CLOCK CREBBP ELL3 MEIS2 KMT2C TFCP2L1 GLI3 ARID2 SS18L1 NFYC NFAT5 MAML3 ZFP62 TBX5 | 1.59e-05 | 1390 | 129 | 23 | GO:0045944 |
| GeneOntologyCellularComponent | chromatin | ERCC6 EP400 SRF POU3F4 SIN3A UPF1 HNF4A FOXJ3 CLOCK CREBBP MEIS2 TFCP2L1 ZFHX4 BRDT ARID2 SS18L1 NFYC BICRAL NFAT5 SAP130 FOXK1 TBX5 | 7.95e-05 | 1480 | 127 | 22 | GO:0000785 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.01e-04 | 96 | 127 | 5 | GO:0070603 | |
| HumanPheno | Abnormal pupillary function | 2.49e-05 | 79 | 39 | 6 | HP:0007686 | |
| HumanPheno | Miosis | 4.54e-05 | 27 | 39 | 4 | HP:0000616 | |
| HumanPheno | Y-shaped metatarsals | 5.71e-05 | 2 | 39 | 2 | HP:0010567 | |
| HumanPheno | Abnormal pupil morphology | 6.24e-05 | 136 | 39 | 7 | HP:0000615 | |
| Domain | DUF4599 | 9.84e-09 | 12 | 126 | 5 | PF15371 | |
| Domain | DUF4599 | 9.84e-09 | 12 | 126 | 5 | IPR027970 | |
| Pubmed | SEMA6C ZSCAN12 EP400 KIF21A AKNA SPG11 SIK3 FOXJ3 CLOCK URGCP KMT2C DST TECPR2 KLHL21 NAV2 DNMBP GARRE1 | 1.84e-11 | 529 | 131 | 17 | 14621295 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | CRTC3 UBQLN1 ANK3 EP400 BEAN1 UBR4 SIN3A TSC22D2 FOXJ3 ZRANB3 MAP4K1 ARID2 IGSF9B SAP130 ADGRL3 | 9.79e-11 | 430 | 131 | 15 | 35044719 |
| Pubmed | 2.87e-09 | 6 | 131 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 2.87e-09 | 6 | 131 | 4 | 25930072 | |
| Pubmed | ZSCAN12 ZSCAN5A SRF FOXJ3 CLOCK MEIS2 IKZF5 ZSCAN5B TFCP2L1 BRDT GLI3 ARID2 SLTM NFYC NFAT5 FOXK1 TBX5 | 1.12e-08 | 808 | 131 | 17 | 20412781 | |
| Pubmed | ASXL1 EP400 SEC24A UBR4 HIPK2 SIN3A UPF1 HNF4A CREBBP IKZF5 KMT2C DST ZFHX4 GLI3 PPIL3 ARID2 SS18L1 NFYC SAP130 PRRC2A GARRE1 FOXK1 | 1.94e-08 | 1429 | 131 | 22 | 35140242 | |
| Pubmed | 2.82e-08 | 24 | 131 | 5 | 32212159 | ||
| Pubmed | CRTC3 HIVEP2 ANK3 HIPK2 SIK3 CREBBP KMT2C DST ARID2 NFYC NAV2 BICRAL TNS1 | 4.29e-08 | 486 | 131 | 13 | 20936779 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | HIVEP2 SRF AKNA POU3F4 TSC22D2 HNF4A FOXJ3 CLOCK MEIS2 HSF5 TFCP2L1 ZFHX4 GLI3 NFYC NFAT5 FOXK1 TBX5 | 6.07e-08 | 908 | 131 | 17 | 19274049 |
| Pubmed | 6.38e-08 | 335 | 131 | 11 | 15741177 | ||
| Pubmed | HIVEP2 SRF POU3F4 TACC2 HNF4A FOXJ3 CREBBP MEIS2 KMT2C TFCP2L1 GLI3 NFAT5 MAML3 FOXK1 TOP3A | 8.10e-08 | 709 | 131 | 15 | 22988430 | |
| Pubmed | 6.58e-07 | 130 | 131 | 7 | 12421765 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CRTC3 HIVEP2 SEC24A MAGI3 PLEKHG2 SIK3 DST STARD9 MAP4K1 KIAA1217 NAV2 DNMBP GARRE1 FOXK1 TNS3 | 9.47e-07 | 861 | 131 | 15 | 36931259 |
| Pubmed | ROBO4 MXRA5 TNC UBR4 IGSF5 SIK3 CSMD2 FOXJ3 CREBBP ARID2 SS18L1 ARHGAP45 MAML3 | 9.48e-07 | 638 | 131 | 13 | 31182584 | |
| Pubmed | ERCC6 EP400 LGR4 SIN3A SIK3 CREBBP ELL3 ZFHX4 BRDT KLHL21 GLI3 ARID2 SS18L1 BICRAL SAP130 GARRE1 FOXK1 | 1.08e-06 | 1116 | 131 | 17 | 31753913 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ZSCAN5A SRF POU3F4 HNF4A FOXJ3 CLOCK MEIS2 HSF5 TFCP2L1 GLI3 NFAT5 FOXK1 | 1.12e-06 | 544 | 131 | 12 | 28473536 |
| Pubmed | Generation and analysis of 280,000 human expressed sequence tags. | SEC16B HIVEP2 SIK3 TSC22D2 CPS1 ADAMTS12 DST NAV2 DNMBP NFAT5 | 1.44e-06 | 368 | 131 | 10 | 8889549 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EP400 HIPK2 TACC2 ZCCHC2 CREBBP PAPOLG ARID2 KIAA1217 DNMBP GARRE1 FOXK1 TOP3A | 2.49e-06 | 588 | 131 | 12 | 38580884 |
| Pubmed | 3.07e-06 | 233 | 131 | 8 | 37704626 | ||
| Pubmed | UBQLN1 EP400 SIN3A UPF1 FOXJ3 CREBBP IKZF5 KMT2C PPIL3 ARID2 BICRAL SAP130 HNRNPLL PRRC2A FOXK1 RAD23B | 4.28e-06 | 1103 | 131 | 16 | 34189442 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ZSCAN12 UFSP2 SIDT1 ZCCHC2 HNF4A ADAMTS12 TENM1 NAV2 IGSF9B TNS1 GARRE1 | 8.33e-06 | 552 | 131 | 11 | 10737800 |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 12185581 | ||
| Pubmed | MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity. | 1.41e-05 | 2 | 131 | 2 | 33824309 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 35954177 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 22740631 | ||
| Pubmed | CBP and SRF co-regulate dendritic growth and synaptic maturation. | 1.41e-05 | 2 | 131 | 2 | 30850733 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 26156069 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 10085149 | ||
| Pubmed | Functional association between CBP and HNF4 in trans-activation. | 1.41e-05 | 2 | 131 | 2 | 9434765 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6C HIVEP2 EP400 UBR4 AKNA DUS1L KMT2C DST KLHL21 NAV2 DNMBP FOXK1 TOP3A RASAL1 CD276 | 1.90e-05 | 1105 | 131 | 15 | 35748872 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.13e-05 | 398 | 131 | 9 | 35016035 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | HIVEP2 POU3F4 SIN3A HNF4A CLOCK CREBBP MEIS2 PAPOLG NCOA5 TFCP2L1 GLI3 SS18L1 MAML3 | 2.87e-05 | 877 | 131 | 13 | 20211142 |
| Pubmed | 3.96e-05 | 332 | 131 | 8 | 37433992 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 17670796 | ||
| Pubmed | Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. | 4.21e-05 | 3 | 131 | 2 | 11740489 | |
| Pubmed | Sin3 interacts with Foxk1 and regulates myogenic progenitors. | 4.21e-05 | 3 | 131 | 2 | 22476904 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 19444904 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 22649236 | ||
| Pubmed | Acetylation regulates transcription factor activity at multiple levels. | 4.21e-05 | 3 | 131 | 2 | 10882110 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 12622724 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 9388250 | ||
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 4.21e-05 | 3 | 131 | 2 | 14716005 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 17000779 | ||
| Pubmed | Sonic Hedgehog-induced activation of the Gli1 promoter is mediated by GLI3. | 4.21e-05 | 3 | 131 | 2 | 10075717 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 9590171 | ||
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 5.68e-05 | 20 | 131 | 3 | 29785026 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.86e-05 | 351 | 131 | 8 | 38297188 | |
| Pubmed | 6.61e-05 | 21 | 131 | 3 | 23650387 | ||
| Pubmed | The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. | 6.61e-05 | 21 | 131 | 3 | 27088858 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 7.40e-05 | 363 | 131 | 8 | 14691545 | |
| Pubmed | CBP/p300 is a cell type-specific modulator of CLOCK/BMAL1-mediated transcription. | 8.41e-05 | 4 | 131 | 2 | 19922678 | |
| Pubmed | Zscan5b Deficiency Impairs DNA Damage Response and Causes Chromosomal Aberrations during Mitosis. | 8.41e-05 | 4 | 131 | 2 | 31155506 | |
| Pubmed | Nuclear protein CBP is a coactivator for the transcription factor CREB. | 8.41e-05 | 4 | 131 | 2 | 7913207 | |
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 30782847 | ||
| Pubmed | A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. | 8.41e-05 | 4 | 131 | 2 | 16427017 | |
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 17728339 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 19166614 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 19194507 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 26164627 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 28398509 | ||
| Pubmed | Foxk proteins repress the initiation of starvation-induced atrophy and autophagy programs. | 8.41e-05 | 4 | 131 | 2 | 25402684 | |
| Pubmed | Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1. | 8.41e-05 | 4 | 131 | 2 | 16606840 | |
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 12840167 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 9194565 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 27732952 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 15591049 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 19205030 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 34504132 | ||
| Pubmed | 1.01e-04 | 282 | 131 | 7 | 23667531 | ||
| Pubmed | CRTC3 ABCC4 COL12A1 UFSP2 ANK3 TNC CPS1 HNF4A KMT2C DST TECPR2 NFYC RPGR SAP130 CA6 | 1.12e-04 | 1293 | 131 | 15 | 15342556 | |
| Pubmed | Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. | 1.16e-04 | 66 | 131 | 4 | 24811749 | |
| Pubmed | Inactivation of tensin3 in mice results in growth retardation and postnatal lethality. | 1.40e-04 | 5 | 131 | 2 | 15733665 | |
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 17190795 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 23991058 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 23121087 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 10823891 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 30242271 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 23033494 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 16315091 | ||
| Pubmed | Cryptochrome 1 regulates the circadian clock through dynamic interactions with the BMAL1 C terminus. | 1.40e-04 | 5 | 131 | 2 | 25961797 | |
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 28128295 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 23321477 | ||
| Pubmed | Evaluation of genetic susceptibility loci for obesity in Chinese women. | 1.40e-04 | 5 | 131 | 2 | 20616199 | |
| Pubmed | Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. | 1.40e-04 | 5 | 131 | 2 | 11827521 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB ABCC4 HIVEP2 ANK3 SRF HIPK2 MAGI3 FOXJ3 CREBBP KMT2C TECPR2 KIAA1217 IGSF9B NFAT5 SAP130 MAML3 | 1.58e-04 | 1489 | 131 | 16 | 28611215 |
| Pubmed | 1.78e-04 | 29 | 131 | 3 | 27320915 | ||
| Pubmed | Multiple roles of mesenchymal beta-catenin during murine limb patterning. | 1.97e-04 | 30 | 131 | 3 | 16495310 | |
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 16055500 | ||
| Pubmed | 14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs). | 2.09e-04 | 6 | 131 | 2 | 29211348 | |
| Pubmed | Genetic analysis of the hypothalamic corticotropin-releasing factor system. | 2.09e-04 | 6 | 131 | 2 | 15705776 | |
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 16678094 | ||
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 15161102 | ||
| Pubmed | Oncogenic activation of c-Myb correlates with a loss of negative regulation by TIF1beta and Ski. | 2.09e-04 | 6 | 131 | 2 | 14761981 | |
| Pubmed | Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. | 2.09e-04 | 6 | 131 | 2 | 20930143 | |
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 16399771 | ||
| Pubmed | Recruitment of Sprouty1 to immune synapse regulates T cell receptor signaling. | 2.09e-04 | 6 | 131 | 2 | 19915061 | |
| Pubmed | 2.10e-04 | 77 | 131 | 4 | 19505873 | ||
| Pubmed | 2.17e-04 | 31 | 131 | 3 | 26222436 | ||
| Pubmed | 2.19e-04 | 225 | 131 | 6 | 12168954 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.37e-04 | 146 | 131 | 5 | 23892456 | |
| Interaction | SMARCA4 interactions | ERCC6 EP400 SRF SIN3A UPF1 SIK3 HNF4A CREBBP TFCP2L1 KCNA3 BRDT GLI3 ARID2 SS18L1 BICRAL TBX5 | 3.56e-08 | 462 | 127 | 16 | int:SMARCA4 |
| Interaction | FHL2 interactions | EP400 SRF HIPK2 SIN3A PLEKHG2 CREBBP PRDM11 KIAA1217 NFYC NFAT5 SAP130 FOXK1 | 7.91e-06 | 396 | 127 | 12 | int:FHL2 |
| Interaction | PAX6 interactions | EP400 HIPK2 CREBBP MEIS2 KMT2C ZFHX4 ARID2 SS18L1 NFYC SAP130 FOXK1 | 2.07e-05 | 366 | 127 | 11 | int:PAX6 |
| Interaction | SP7 interactions | EP400 SIN3A CREBBP KMT2C ZFHX4 PPIL3 ARID2 SS18L1 SAP130 FOXK1 | 2.32e-05 | 304 | 127 | 10 | int:SP7 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 2.24e-04 | 8 | 131 | 2 | chr9q12 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.92e-05 | 161 | 80 | 6 | 593 | |
| GeneFamily | Collagens|Collagen proteoglycans | 1.92e-04 | 5 | 80 | 2 | 575 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 5.32e-04 | 8 | 80 | 2 | 837 | |
| GeneFamily | Fibronectin type III domain containing | 7.18e-04 | 160 | 80 | 5 | 555 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.52e-03 | 17 | 80 | 2 | 486 | |
| Coexpression | LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B | 4.72e-08 | 103 | 130 | 8 | M39240 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FLNB ASXL1 HIVEP2 SEC24A SPG11 SIK3 TSC22D2 FOXJ3 CLOCK CREBBP MEIS2 UTP18 DST NFYC BICRAL RPGR DNMBP GARRE1 RAD23B | 4.77e-08 | 856 | 130 | 19 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | FLNB HIVEP2 SEC24A FOXJ3 CLOCK CREBBP MEIS2 UTP18 DST NFYC RPGR DNMBP RAD23B | 5.95e-07 | 466 | 130 | 13 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.01e-06 | 208 | 130 | 9 | M39233 | |
| Coexpression | GSE13306_TREG_VS_TCONV_SPLEEN_UP | 7.32e-06 | 200 | 130 | 8 | M3224 | |
| Coexpression | AIZARANI_LIVER_C10_MVECS_1 | 8.25e-06 | 269 | 130 | 9 | M39114 | |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 1.12e-05 | 152 | 130 | 7 | M39239 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 2.73e-05 | 240 | 130 | 8 | M39236 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.99e-05 | 177 | 130 | 7 | M39245 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP | 5.90e-05 | 197 | 130 | 7 | M6512 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 5.96e-05 | 268 | 130 | 8 | M45796 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP | 6.49e-05 | 200 | 130 | 7 | M8042 | |
| Coexpression | GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN | 6.49e-05 | 200 | 130 | 7 | M6607 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 7.01e-05 | 86 | 130 | 5 | M39247 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | SPRY1 MXRA5 COL12A1 TNC TACC2 PALMD MEIS2 ZFHX4 GLI3 KIAA1217 NAV2 TNS3 CD276 | 1.18e-04 | 767 | 130 | 13 | M39209 |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.27e-04 | 155 | 130 | 6 | M39246 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ROBO4 FLNB COL12A1 PALMD MEIS2 KMT2C DST HMCN1 KIAA1217 GARRE1 ADGRL3 | 2.02e-11 | 200 | 131 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | ASXL1 MXRA5 COL12A1 COL15A1 NCOA5 ADAMTS12 DNMBP GARRE1 TNS3 | 4.89e-09 | 188 | 131 | 9 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 7.35e-09 | 197 | 131 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.38e-09 | 200 | 131 | 9 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-08 | 155 | 131 | 8 | 82e602f31981c6b48abff2a04b2ab5d26d4462a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-08 | 155 | 131 | 8 | 979c1d53b435a82c57d16707eed8ba7346326866 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 4.10e-08 | 170 | 131 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-08 | 184 | 131 | 8 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-08 | 190 | 131 | 8 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-08 | 190 | 131 | 8 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-07 | 191 | 131 | 8 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-07 | 192 | 131 | 8 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-07 | 192 | 131 | 8 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-07 | 192 | 131 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-07 | 192 | 131 | 8 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.18e-07 | 195 | 131 | 8 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 196 | 131 | 8 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 131 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 131 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 131 | 8 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 131 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 5.51e-07 | 163 | 131 | 7 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.75e-07 | 168 | 131 | 7 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 9.59e-07 | 177 | 131 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.95e-07 | 178 | 131 | 7 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 184 | 131 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 184 | 131 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 184 | 131 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-06 | 187 | 131 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 188 | 131 | 7 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 188 | 131 | 7 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.43e-06 | 188 | 131 | 7 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-06 | 189 | 131 | 7 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.49e-06 | 189 | 131 | 7 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-06 | 189 | 131 | 7 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-06 | 191 | 131 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-06 | 191 | 131 | 7 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-06 | 191 | 131 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-06 | 192 | 131 | 7 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.65e-06 | 192 | 131 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.71e-06 | 193 | 131 | 7 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-06 | 193 | 131 | 7 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 194 | 131 | 7 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-06 | 194 | 131 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 194 | 131 | 7 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 194 | 131 | 7 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 194 | 131 | 7 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.83e-06 | 195 | 131 | 7 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-06 | 195 | 131 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-06 | 195 | 131 | 7 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-06 | 195 | 131 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-06 | 196 | 131 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-06 | 196 | 131 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 197 | 131 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 197 | 131 | 7 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 197 | 131 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.02e-06 | 198 | 131 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | 367C-Endothelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 199 | 131 | 7 | 636ff80938907f137e955388797072ab45289062 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.09e-06 | 199 | 131 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.09e-06 | 199 | 131 | 7 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 199 | 131 | 7 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 199 | 131 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 199 | 131 | 7 | 29ed081bd5204a32068b420f2244f3704891547b | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 199 | 131 | 7 | c2d85f80037f209a4a329790f475d9f98f590262 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.09e-06 | 199 | 131 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.16e-06 | 200 | 131 | 7 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-06 | 200 | 131 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.16e-06 | 200 | 131 | 7 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.16e-06 | 200 | 131 | 7 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.16e-06 | 200 | 131 | 7 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-06 | 200 | 131 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 7.16e-06 | 157 | 131 | 6 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.56e-06 | 162 | 131 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 168 | 131 | 6 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 168 | 131 | 6 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 169 | 131 | 6 | 1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 169 | 131 | 6 | 58098f8801ca941aeddafb47e88ab0df8b9edb57 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-05 | 172 | 131 | 6 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-05 | 172 | 131 | 6 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-05 | 172 | 131 | 6 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 174 | 131 | 6 | 6987fe7959afce347282f632abc16d800ccab7c4 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.29e-05 | 174 | 131 | 6 | 4a1b67ce5ea353b3f81f59fa57da07668146afca | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-05 | 175 | 131 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 175 | 131 | 6 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 175 | 131 | 6 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.37e-05 | 176 | 131 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-05 | 177 | 131 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-05 | 177 | 131 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 177 | 131 | 6 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-05 | 178 | 131 | 6 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 178 | 131 | 6 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-05 | 179 | 131 | 6 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-05 | 180 | 131 | 6 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.81e-07 | 175 | 126 | 9 | 5908_DN | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.26e-06 | 192 | 126 | 9 | 2919_DN | |
| Drug | Methylene Chloride | 3.57e-06 | 163 | 126 | 8 | ctd:D008752 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 5.08e-06 | 171 | 126 | 8 | 7535_DN | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.38e-05 | 196 | 126 | 8 | 1864_DN | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.38e-05 | 196 | 126 | 8 | 1082_UP | |
| Disease | longitudinal alcohol consumption measurement | 6.12e-06 | 9 | 125 | 3 | EFO_0007645 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.91e-04 | 67 | 125 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | beta-1,4-galactosyltransferase 7 measurement | 2.64e-04 | 6 | 125 | 2 | EFO_0802314 | |
| Disease | renal overload-type gout | 2.64e-04 | 6 | 125 | 2 | EFO_0021525 | |
| Disease | Age related macular degeneration | 2.77e-04 | 30 | 125 | 3 | C0242383 | |
| Disease | Asperger syndrome | 3.69e-04 | 7 | 125 | 2 | EFO_0003757 | |
| Disease | eosinophil cationic protein measurement | 4.90e-04 | 8 | 125 | 2 | EFO_0010913 | |
| Disease | Attached earlobe | 4.90e-04 | 8 | 125 | 2 | HP_0009907 | |
| Disease | major depressive disorder | 5.30e-04 | 155 | 125 | 5 | MONDO_0002009 | |
| Disease | cortical surface area measurement | SPRY1 FLNB ANK3 SIDT1 HIPK2 TSC22D2 CPS1 CRHR1 MEIS2 GLI3 RP1L1 NAV2 TNS1 PRRC2A RAD23B | 5.80e-04 | 1345 | 125 | 15 | EFO_0010736 |
| Disease | X-21467 measurement | 6.29e-04 | 9 | 125 | 2 | EFO_0020007 | |
| Disease | neutrophil count | SEMA6C FLNB HIVEP2 MAGI3 IFITM2 PLEKHG2 SIK3 ZCCHC2 CPS1 HNF4A CREBBP ZRANB3 RP1L1 ARHGAP45 TNS3 | 7.65e-04 | 1382 | 125 | 15 | EFO_0004833 |
| Disease | immunoglobulin isotype switching measurement | 8.66e-04 | 44 | 125 | 3 | EFO_0010128 | |
| Disease | cortical thickness | FLNB COL12A1 SIDT1 LGR4 TACC2 TSC22D2 CLOCK CRHR1 GLI3 NAV2 FHIT TNS1 RAD23B | 9.01e-04 | 1113 | 125 | 13 | EFO_0004840 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 9.43e-04 | 364 | 125 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | argininosuccinate measurement | 9.55e-04 | 11 | 125 | 2 | EFO_0010461 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 9.82e-04 | 103 | 125 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 9.86e-04 | 46 | 125 | 3 | EFO_0008003, GO_0097332 | |
| Disease | response to xenobiotic stimulus | 1.09e-03 | 182 | 125 | 5 | GO_0009410 | |
| Disease | free androgen index | 1.10e-03 | 374 | 125 | 7 | EFO_0007005 | |
| Disease | cleft palate (is_implicated_in) | 1.14e-03 | 12 | 125 | 2 | DOID:674 (is_implicated_in) | |
| Disease | body fat percentage | 1.15e-03 | 488 | 125 | 8 | EFO_0007800 | |
| Disease | Prostatic Neoplasms | 1.27e-03 | 616 | 125 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.27e-03 | 616 | 125 | 9 | C0376358 | |
| Disease | egg allergy measurement, parental genotype effect measurement | 1.35e-03 | 13 | 125 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | Fetal Alcohol Spectrum Disorders | 1.35e-03 | 13 | 125 | 2 | C2985290 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.66e-03 | 55 | 125 | 3 | C0079744 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 1.80e-03 | 15 | 125 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | urate measurement, spine bone mineral density | 1.93e-03 | 58 | 125 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | amygdala volume change measurement | 2.05e-03 | 16 | 125 | 2 | EFO_0021490 | |
| Disease | waist-hip ratio | SEC16B COL15A1 ANK3 LGR4 SIK3 TSC22D2 CLOCK CRHR1 MEIS2 UTP18 GLI3 NFAT5 MAML3 | 2.13e-03 | 1226 | 125 | 13 | EFO_0004343 |
| Disease | FEV/FEC ratio | ASXL1 HIVEP2 COL15A1 IFITM2 DST HMCN1 BRDT NAV2 CCDC17 TNS1 CD276 TBX5 RAD23B | 2.16e-03 | 1228 | 125 | 13 | EFO_0004713 |
| Disease | mood instability measurement | 2.18e-03 | 128 | 125 | 4 | EFO_0008475 | |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 2.32e-03 | 17 | 125 | 2 | EFO_0008270 | |
| Disease | Fetal Alcohol Syndrome | 2.32e-03 | 17 | 125 | 2 | C0015923 | |
| Disease | waist circumference | 2.40e-03 | 429 | 125 | 7 | EFO_0004342 | |
| Disease | Age-related macular degeneration | 2.61e-03 | 18 | 125 | 2 | cv:C0242383 | |
| Disease | squamous cell carcinoma (is_implicated_in) | 2.61e-03 | 18 | 125 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | smoking cessation | 2.67e-03 | 325 | 125 | 6 | EFO_0004319 | |
| Disease | Osteoarthritis of hip | 3.22e-03 | 20 | 125 | 2 | C0029410 | |
| Disease | serum homoarginine measurement | 3.22e-03 | 20 | 125 | 2 | EFO_0005421 | |
| Disease | citrulline measurement | 3.22e-03 | 20 | 125 | 2 | EFO_0009777 | |
| Disease | apolipoprotein A 1 measurement | AKNA SPG11 SIK3 TSC22D2 CPS1 HNF4A ZRANB3 KANK4 CCDC17 FOXK1 | 3.32e-03 | 848 | 125 | 10 | EFO_0004614 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.34e-03 | 144 | 125 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | Manic Disorder | 3.44e-03 | 71 | 125 | 3 | C0024713 | |
| Disease | attention function measurement | 3.68e-03 | 148 | 125 | 4 | EFO_0007636 | |
| Disease | age at menarche | 3.87e-03 | 594 | 125 | 8 | EFO_0004703 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VMQTVSQAGAVHGAL | 1676 | Q96L91 | |
| AAGQTVVAQPVHMQQ | 2951 | Q96L91 | |
| GHPTQEMTFGAQASV | 36 | Q96LX7 | |
| PGAEQTGIQNKTQMH | 191 | Q9Y6F7 | |
| NQGQSLPGSSREHMA | 171 | Q9HB65 | |
| LTQVGVSQGHNMCPD | 331 | Q7Z408 | |
| EQLSNGITVMHPSGD | 766 | Q58F21 | |
| TSVMDTLPLNGNHGN | 1191 | Q9HAR2 | |
| NLTATQMSFPVQGVH | 661 | Q68CP9 | |
| QMSFPVQGVHTVAQT | 666 | Q68CP9 | |
| ETLTQVSPQMTGHAG | 241 | Q92793 | |
| VSPQMTGHAGLNTAQ | 246 | Q92793 | |
| VQGVMSAEGNLHNPA | 226 | Q6P1R4 | |
| GPQAQGLVMEAATHS | 526 | Q6XZF7 | |
| QQDAHGSVTITGQPM | 446 | Q5ZPR3 | |
| GEFPMVNNGHTVQIS | 76 | P23280 | |
| VNNGHTVQISLPSTM | 81 | P23280 | |
| MNLHQVLTGAVNPGD | 1 | Q9Y485 | |
| TGVMQIETGPANHIF | 2981 | Q9Y485 | |
| MPNEGIPHSSQTQEQ | 1 | Q03468 | |
| PLNGEHTQAGTAMSR | 701 | Q8IXJ9 | |
| NMVTGLFHNPSIGNA | 276 | P58397 | |
| QLPHVMQVVTQDGTG | 631 | O95294 | |
| EAGSGHMNYIQVTPQ | 351 | P54727 | |
| AANTVDITQPGQHMA | 461 | O75916 | |
| HSNQHMNTVDQPLGV | 176 | Q6ZSG2 | |
| NPSGSVVMVSGLHQL | 331 | Q8WVV9 | |
| MPNEGIPHSSQTQEQ | 1 | P0DP91 | |
| TNGLGIGVNESIHNM | 291 | Q9NP74 | |
| VGAATGAHSQMQLVQ | 11 | A0A0C4DH39 | |
| GAHSQMQLVQSGPEV | 16 | A0A0C4DH39 | |
| GQQMLGQISATSHIN | 1341 | P10071 | |
| PMHSQGQQFSGVSQL | 2341 | Q8NEZ4 | |
| TSVTGQVLGGPHNLM | 101 | Q9H2X6 | |
| GHSMVQAVGTLQTQT | 351 | Q92619 | |
| MGQSQANHIPGDRSA | 961 | Q5TCQ9 | |
| GQSMLVNSAITQQHP | 916 | Q96JK9 | |
| MNHIVQTFSPVNSGQ | 1 | Q01629 | |
| SQGPVGMETETINQQ | 5306 | Q03001 | |
| NSVDPNVGGQVMDIH | 461 | O14770 | |
| NVIVANTMPTHLSNG | 401 | P41235 | |
| NGNHVANSPVSIMVV | 1981 | O75369 | |
| HLVSQTTAQMGQPQA | 556 | Q9HCD5 | |
| VPGQTVSEEATGVHM | 186 | Q9UHL3 | |
| GPQAHMQQVTSSLKG | 121 | Q9BYJ0 | |
| VIEEGGMNHSAFPQT | 531 | P22001 | |
| ASMVQQFPNLTGTVH | 306 | Q9BXB1 | |
| QQTHHVNMISGSVSG | 21 | Q9H5V7 | |
| QPQATLFHNTAGGTM | 1416 | O94916 | |
| GQTTPVTMQVGEGQQ | 186 | Q13952 | |
| SLVHADSAGMQQGSP | 16 | P49335 | |
| LQVHVAPSISGSNNM | 2006 | Q96RW7 | |
| GHTDHMVTNTSNGQP | 1301 | O15439 | |
| QGQPHLNGMSNITKT | 626 | Q9BWT3 | |
| FQTHDQIGMISAGPS | 971 | Q92900 | |
| MGVHTGDSVVVAPAQ | 656 | P31327 | |
| SMQDGPEAGQTVKHV | 81 | P49789 | |
| GGNFTSEMIIHNVEP | 101 | Q9NSI5 | |
| PSMNQVHVGGSLAVL | 496 | Q9UJP4 | |
| QGSVVGPHMSVNIVN | 351 | Q6AI39 | |
| MTAGSRQHALSVGPQ | 371 | Q99715 | |
| TISHMNVTGPQIRDG | 466 | Q8TD84 | |
| GSNSVAQVSLSHPQM | 361 | Q9UPW0 | |
| HFGSMSVGNSVNNIP | 296 | Q6UUV7 | |
| SVGNSVNNIPAAMTH | 301 | Q6UUV7 | |
| FNMGQSHQGSPLVTR | 656 | O15063 | |
| QTVASQMAPGVPGHT | 586 | P85037 | |
| QPNHSIHTGMVPQGT | 481 | Q7Z591 | |
| QMPGHAEVALVNGSI | 1706 | Q12955 | |
| VQLTMSPEVHQSNVG | 201 | P34998 | |
| TQGQTDVMVNTDPVH | 406 | Q5T7N3 | |
| EQRTPAQGGLHTVSM | 196 | Q3B7T3 | |
| NMSIIQHSSPKQGSG | 306 | P39059 | |
| GQDLQHISNQKMPTG | 56 | Q6PGQ1 | |
| MNVGTAHSEVNPNTR | 1 | Q8N138 | |
| FNVGSNTNETITMPH | 146 | Q9ULK6 | |
| GEMSTEHRGPVQVTQ | 701 | Q92918 | |
| QHVSQGIFMTQPATT | 561 | Q92834 | |
| VHVQQGPQTMVSSSQ | 276 | Q4G112 | |
| SVQFHPGAQIVMVAG | 256 | Q9Y5J1 | |
| ASQVPQGHLQSMPTG | 896 | B4DYI2 | |
| VVVVASMQGAHGPES | 226 | O75157 | |
| GSPQLGEGMFQHQTS | 446 | Q99593 | |
| EGITSNTNNGSMVVH | 246 | O95486 | |
| TTMTHGVQNIGQTQG | 381 | Q9NQV5 | |
| SQVPQGHLQSMPTGN | 1051 | Q8IWB4 | |
| VVISNPHATMTQQGN | 1346 | Q8IVL1 | |
| SQISGGAMDSQLHPN | 1846 | P48634 | |
| AGMITQHSSNASPIN | 991 | Q9NWH9 | |
| TNPGSFVLTGMHNGQ | 526 | Q92529 | |
| QMQEQGKGNLHVTSP | 21 | Q5T5P2 | |
| TNDMVNVTTPGQVHQ | 196 | Q96ST3 | |
| MIQPHGAASSSQFQG | 756 | Q9Y2K2 | |
| PVISTIMGNGHQRSV | 1166 | Q9UKZ4 | |
| ASVQQHGIQSAQGMS | 691 | Q8TF17 | |
| GAMEVNSIGNHPQVQ | 2131 | Q9P2P6 | |
| PQGHLQSTPTGNMQA | 906 | P0DKV0 | |
| IPTHMNALGSQANGS | 716 | Q68CZ2 | |
| GPTGIHVVVSNEMVQ | 436 | Q9NZI6 | |
| SGQKEVHGMAQPSQN | 171 | Q99470 | |
| MQVSHSQVQEPGGVP | 441 | P11831 | |
| GEQTQLEIATHMPGS | 401 | Q8WZ75 | |
| VEGGHVNMAFSQSNP | 1471 | Q9UM73 | |
| QAAINALHGSQTMPG | 206 | Q9BZC1 | |
| VVPTNQIQSGMNTGH | 601 | O15516 | |
| QIQSGMNTGHIGTTQ | 606 | O15516 | |
| GQIGNGPSHVSMQQT | 121 | O75177 | |
| LANHFQSEGTPVMIG | 386 | Q9NUQ7 | |
| ANGLVHDPVMGSQAN | 1081 | Q9C0B9 | |
| QGTGHKQMFNPTEES | 2066 | Q96JI7 | |
| SQVPQGHLQSMPTGN | 1051 | Q5VYP0 | |
| RMQQNGHDPSSGVQE | 536 | Q8TCY9 | |
| HSIAANVNSPGQGML | 1591 | Q86UP3 | |
| MGQEHTQAQPTQGAA | 1486 | Q8IWN7 | |
| SQVPQGHLQSMPTGN | 1051 | Q5VU36 | |
| SQGQLRHTSQGMGIP | 1131 | Q9UPX0 | |
| TGQEIMSLGGHPNNV | 1376 | Q7Z4S6 | |
| SNDGSGNMVASHPIA | 346 | Q9NXL6 | |
| HNVRGVVSMANNGPN | 81 | Q9H2H8 | |
| GTTEPGHQQFIQQML | 516 | Q9UMX0 | |
| ASSVNQMHPGTGQAR | 166 | A6NJL1 | |
| QTGVGVASTVHLNPM | 531 | Q9H0E3 | |
| IQGMEHLENGPSVSV | 311 | Q9HBL0 | |
| EVMVSGFTQGHQTKP | 1596 | P24821 | |
| ASSVNQMRPGEGQAH | 166 | Q9BUG6 | |
| NRESPGQAGMNSIHS | 321 | Q9BUG6 | |
| VAVDGMAGPHSNITV | 426 | Q9H3T2 | |
| MDPQNQHGSGSSLVV | 1 | O43609 | |
| ALDTIDVQGHPQTGM | 366 | O95359 | |
| GVSLVSVHSSPNDQM | 1266 | O15040 | |
| EMLQTHLGPGENTVS | 826 | Q96JE7 | |
| QGSHFQPSTVEMVDG | 496 | Q13472 | |
| PIVIDGSNVAMSHGN | 91 | A2A288 | |
| ITHQTMPIGQRGSEQ | 101 | Q8NB50 | |
| STQESMGLHRAQGAP | 1366 | Q9H7P9 | |
| MSTFGSHEGQRQPQI | 36 | P31629 | |
| MQSSGIPNGGHIRQE | 2741 | Q5T4S7 | |
| PGEQVSVHTGEQEMF | 131 | O43309 | |
| HQGVSLTMEGTVNLQ | 36 | O14972 | |
| TPQGSAVMQIDSLNH | 646 | Q5FWF4 | |
| ATPVNNEGTQHMSGP | 1541 | Q9NR99 | |
| NEGTQHMSGPNELST | 1546 | Q9NR99 |